References
- Jaen A, Ferrer A, Ormaza I, et al. Prevalence of chronic bronchitis, asthma and airflow limitation in an urban-industrial area of Catalonia. Arch Bronconeumol 1999;35:122-8
- Domingo C. Effectiveness and efficiency of an outpatient clinic for corticosteroid-dependent asthmatics. Arch Bronconeumol 2001;37:274-80
- Global Initiative for Asthma Treatment (GINA) guidelines. Available at: www.ginasthma.com
- Marin MG. Low-dose methotrexate spares steroid usage in steroid-dependent chronic asthmatic patients: a meta-analysis. Chest 1997;112:29-33
- Aaron SD, Dales RE, Pham B. Management of steroid-dependent asthma with methotrexate: a meta-analysis and randomised clinical trials. Respir Med 1998;92:1059-65
- Davies H, Olson L, Gibson P. Methotrexate as a steroid sparing agent for asthma in adults. Cochrane Database Syst Rev 2008;(3): CD000391. Oxford: Update Software Ltd
- Domingo Ch, Ferrer A, Torremorell MD, et al. Methotrexate as a steroid-sparing agent in bronchial asthma: preliminary results. Chest 1994;106 (Suppl):108s
- Domingo C, Comet R, Bosque M, et al. Efficiency of methotrexate in the treatment of cortico-dependent asthmatic patients. Rev Clin Esp 1999;199:142-6
- Comet R, Domingo C, Larrosa M, et al. Benefits of low weekly doses of methotrexate in steroid-dependent asthmatic patients. A double-blind, randomized, placebo-controlled study. Respir Med 2006;100:411-19
- Mullarkey MF, Blumenstein BA, Andrade WP, et al. Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study. N Engl J Med 1988;318:603-7
- National Heart, Lung and Blood Institute, National Institutes of Health. Bethesda, Maryland 20892. Publication number 92-3091, March 1992. Eur Respir J 1992;5:601-41
- GEMA (the Spanish guide for the management of asthma). Available at: www.gemasma.com
- Roca J, Sanchis J, Agusti-Vidal A, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 1986;22:217-24
- Karch FE, Lassagna L. Towards the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977;21:247-54
- Domingo Ch, Roig J. Neglected respiratory toxicity caused by cancer therapy. Open Respir Med J 2007;1:1-6
- Mullarkey MF, Webb DR, Pardee NE. Methotrexate in the treatment of steroid-dependent asthma. Ann Allergy 1986;56:347-50
- Erzurum SC, Leff JA, Cochran JE, et al. Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study. Ann Intern Med 1991;114:353-60
- Taylor DR, Flannery EM, Hervison HGP. Methotrexate in the management of severe steroid dependent asthma. NZ Med J 1993;106:409-11
- Coffey MJ, Sanders G, Eschenbacher WL, et al. The role of methotrexate in the management of steroid dependent asthma. Chest 1994;105:117-21
- Shiner RJ, Nunn AJ, Chung KF, et al. Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet 1990;336:137-40
- Mullarkey MF, Lammert JK, Blumenstein BA. Long-term methotrexate treatment in corticosteroid-dependent asthma. Ann Intern Med 1990;112:577-81
- Jones G, Mierins E, Karsh J. Methotrexate-induced asthma. Am Rev Respir Dis 1991;143:179-81
- Roig J, Domingo Ch, Sanchez E. Pulmonary toxicity caused by cytotoxic drugs. Clin Pulm Med 2006;13:53-62
- Valleran H, Cossart C, Milosevic D, et al. Fatal Pneumocystis pneumonia in asthmatic patient treated with methotrexate. Lancet 1992;339:1551
- Domingo Ch, Masdeu MJ, Gallego M. Infrequent chronic infections in COPD. Curr Resp Med Rev 2006;2:357-71
- Corrigan CJ, Shiner RJ, Shakur BH, et al. Methotrexate therapy of oral corticosteroid-dependent asthmatics reduces serum immunoglobulins: correlation with clinical response to therapy. Clin Exp Allergy 2005;35:579-84
- Holgate ST, Polosa R. The mechanisms, diagnosis and management of severe asthma in adults. Lancet 2006;368:780-93
- Salpeter SR, Buckley NS, Ormiston TM, et al. Meta-analysis: effect of long-acting β-agonists on severe asthma exacerbations and asthma related deaths. Ann Intern Med 2006;144:904-12
- Domingo Ch. Mortality and β-agonists, or the risk of statistical inference. Arch Bronconeumol 2007;43:355-7
- Owen CE, Fox HG, Walker C. WO06082052 (2006)
- Domingo Ch, Pacheco A, Hinojosa M, et al. The relevance of IgE in the pathogenesis of allergy: the effect of an anti-IgE drug in asthma and other diseases. Recent Patents Inflamm Allergy Drug Discov 2007;1:151-64